What is Scrofula?

Scrofula, historically known as “the King’s Evil,” is a distinctive manifestation of extrapulmonary tuberculosis, primarily affecting the lymph nodes in the neck. Unlike the more common pulmonary tuberculosis, which targets the lungs, scrofula presents as chronic, painless swelling of the cervical lymph nodes, often progressing to abscess formation, ulceration, and eventual drainage of purulent material. This condition has a long and fascinating history, deeply intertwined with medical understanding, societal beliefs, and even royal touch healing practices. While less prevalent in modern developed nations due to advancements in public health and antitubercular treatments, scrofula remains a significant health concern in regions where tuberculosis is endemic.

Historical Context and Etymology

The term “scrofula” originates from the Latin scrofula, meaning a “brood sow,” likely alluding to the swollen, nodular appearance of the affected lymph nodes resembling the neck of a pig. Throughout antiquity and the Middle Ages, scrofula was a common ailment, frequently misdiagnosed or attributed to various supernatural causes. Its persistent, disfiguring nature made it a dreaded condition, often leading to social stigmatization and isolation.

The King’s Evil

One of the most remarkable aspects of scrofula’s history is its association with monarchical healing. From the 11th century in England and France, it was believed that the touch of a divinely appointed king could cure scrofula. This practice, known as “the King’s Evil” or “the Royal Touch,” persisted for centuries, with monarchs conducting elaborate ceremonies where they would lay hands upon scrofula sufferers. While the perceived cures were likely due to natural remission, the placebo effect, or misdiagnosis, this tradition underscored the mysterious and formidable nature of the disease in the public imagination. The ritual ceased in England with Queen Anne in the early 18th century and in France after Charles X in the 19th century, coinciding with a more scientific understanding of disease.

Pathogenesis and Etiology

Scrofula is almost exclusively caused by Mycobacterium tuberculosis, the same bacterium responsible for pulmonary tuberculosis. In some cases, particularly in children or immunocompromised individuals, atypical mycobacteria (non-tuberculous mycobacteria or NTM) can also cause a similar condition, referred to as non-tuberculous mycobacterial lymphadenitis.

Transmission and Infection

The primary mode of transmission for Mycobacterium tuberculosis is through airborne droplets from an infected individual with active pulmonary tuberculosis. However, scrofula itself is not typically contagious through direct contact with the cervical lesions. The infection usually originates from a primary tuberculous focus elsewhere in the body (often the lungs, tonsils, or gastrointestinal tract), from which the bacteria disseminate via lymphatic channels to the regional lymph nodes in the neck. Ingestion of contaminated milk (from cows infected with Mycobacterium bovis) was once a common cause, particularly before pasteurization became widespread, but this is now rare in countries with strict dairy regulations.

Clinical Presentation

The hallmark of scrofula is the insidious onset of a firm, rubbery, and typically painless swelling of one or more cervical lymph nodes. These swellings are usually unilateral and most commonly affect the anterior or posterior cervical chains, often in the submandibular or supraclavicular regions. Over weeks or months, the nodes may enlarge, become matted together, and develop into a fluctuant mass (an abscess). Without treatment, the skin overlying the abscess can thin, become discolored (purplish), and eventually ulcerate, leading to the discharge of characteristic “caseous” or cheesy pus. This persistent drainage can form sinuses that heal with disfiguring scars. Unlike acute bacterial lymphadenitis, systemic symptoms such as fever, night sweats, and weight loss are often absent or mild in scrofula, especially in early stages.

Diagnosis and Differential Diagnosis

Diagnosing scrofula requires a combination of clinical suspicion, imaging, and definitive microbiological or histopathological confirmation. Given its slow progression and often subtle systemic symptoms, it can sometimes be mistaken for other neck masses.

Diagnostic Procedures

1. Clinical Examination: Identification of chronic, painless cervical lymphadenopathy.
2. Tuberculin Skin Test (TST) or Interferon-Gamma Release Assays (IGRAs): These tests indicate exposure to tuberculosis but do not differentiate between active and latent infection, nor do they specify the site of disease.
3. Imaging: Ultrasound can characterize the lymph nodes (size, internal architecture, presence of necrosis). CT scans or MRI can provide more detailed anatomical information, particularly useful for assessing the extent of disease and ruling out other pathologies.
4. Fine Needle Aspiration Cytology (FNAC) with Acid-Fast Bacilli (AFB) Stain and Culture: This is often the initial diagnostic step. Aspiration of material from the swollen nodes can reveal granulomatous inflammation and, ideally, allow for direct visualization of AFB and mycobacterial culture. Culture is crucial for confirming the diagnosis, identifying the specific mycobacterial species (M. tuberculosis vs. NTM), and performing drug susceptibility testing.
5. Excisional Biopsy: If FNAC is inconclusive, or if the diagnosis remains uncertain, surgical excision of an affected lymph node for histopathological examination is considered the gold standard. Histology typically shows characteristic caseating granulomas with Langhans giant cells.

Differential Diagnosis

It is critical to differentiate scrofula from other causes of cervical lymphadenopathy, including:

• Bacterial Lymphadenitis: Usually acute, painful, and often associated with systemic signs of infection.
• Cat Scratch Disease: Caused by Bartonella henselae, often following exposure to cats, presenting with regional lymphadenopathy.
• Toxoplasmosis: Another parasitic infection that can cause chronic lymph node swelling.
• Lymphoma: Malignant proliferation of lymphocytes, which can present as painless, progressive lymphadenopathy.
• Metastatic Carcinoma: Spread of cancer from a primary site to cervical lymph nodes, often in older patients.
• Kikuchi-Fujimoto Disease (Histiocytic Necrotizing Lymphadenitis): A benign, self-limiting condition causing painful cervical lymphadenopathy, primarily in young women.

Treatment and Prognosis

The treatment for scrofula mirrors that of pulmonary tuberculosis and involves a prolonged course of multiple antitubercular drugs. The specific regimen and duration depend on the infecting organism (tuberculous vs. non-tuberculous mycobacteria) and drug susceptibility patterns.

Antitubercular Therapy

For Mycobacterium tuberculosis infection, the standard treatment typically involves a combination of four drugs (isoniazid, rifampicin, pyrazinamide, and ethambutol) for an initial intensive phase (2 months), followed by a continuation phase of two drugs (isoniazid and rifampicin) for 4-7 months, totaling 6-9 months of treatment. Adherence to the full course of medication is paramount to prevent drug resistance and recurrence.

Surgical Intervention

Surgical excision of the affected lymph nodes may be considered in specific circumstances:

• For diagnostic purposes when FNAC is inconclusive.
• For large, unsightly masses that cause cosmetic concern.
• For persistent draining sinuses or abscesses that fail to respond to antitubercular therapy.
• To distinguish between tuberculous and non-tuberculous mycobacterial infections, as NTM infections often respond better to surgical removal than to medication alone.

Prognosis

With appropriate and timely antitubercular treatment, the prognosis for scrofula is generally excellent, with most patients achieving complete resolution. However, delayed diagnosis or inadequate treatment can lead to persistent disfigurement, chronic draining sinuses, and potential spread of the infection to other parts of the body. Scarring is a common sequela, particularly in cases involving ulceration and drainage.

Prevention

Prevention of scrofula is essentially the prevention of tuberculosis. This includes:

• Vaccination: The Bacillus Calmette-Guérin (BCG) vaccine, while offering varying efficacy against pulmonary tuberculosis in adults, is more effective in preventing severe forms of tuberculosis in children, including scrofula.
• Public Health Measures: Early diagnosis and treatment of individuals with active pulmonary tuberculosis to interrupt transmission, contact tracing, and improved sanitation and living conditions.
• Pasteurization of Milk: Critical in preventing Mycobacterium bovis transmission.

While scrofula is a disease with deep historical roots, its understanding and treatment have evolved dramatically. Modern medicine has transformed it from a mysterious and often fatal affliction into a treatable condition, though vigilance remains crucial in areas where tuberculosis continues to pose a public health challenge.